A prominent pro-life organization is calling on President Trump's health agencies to immediately suspend approval of the abortion drug mifepristone, alleging years of "reckless distribution" that has endangered women's lives across America.
Live Action, one of the nation's leading pro-life advocacy groups, is demanding that the Department of Health and Human Services and the FDA take swift action to halt what they describe as the dangerous proliferation of chemical abortion pills that were fast-tracked under previous administrations.
The timing couldn't be more significant. With Trump back in the White House and a pro-life administration firmly in control, Patriots finally have leaders willing to prioritize women's safety over the abortion industry's profits.
Years of FDA Negligence Exposed
For too long, the swamp creatures at the FDA have allowed Big Abortion to push these dangerous drugs with minimal oversight. While the mainstream media refuses to report on the serious complications and emergency room visits linked to mifepristone, grassroots organizations like Live Action are doing the real investigative work.
The abortion pill regimen has been linked to numerous adverse events, including severe bleeding, infection, and incomplete abortions that require emergency surgical intervention. Yet the FDA under previous administrations continued to loosen restrictions, even allowing mail-order distribution during COVID – putting profits before women's health.
"The reckless distribution of these dangerous drugs has gone on far too long. It's time for the Trump administration to put women's safety first," the organization stated in their urgent appeal.
This represents exactly the kind of swamp-draining action that millions of Americans voted for in 2024. While the Biden regime kowtowed to Planned Parenthood and the abortion lobby, Trump's team has the backbone to stand up for life and genuine women's health.
With HHS Secretary nominees and FDA leadership changes on the horizon, pro-life Americans finally have hope that our federal health agencies will prioritize science and safety over woke ideology. The question now is: will Trump's team act swiftly to protect American women from these dangerous drugs?